Esophageal metastases and dysphagia in patients with carcinoma of the breast
β Scribed by E. Douglas Holyoke; Takuma Nemoto; Thomas L. Dao
- Publisher
- John Wiley and Sons
- Year
- 1969
- Tongue
- English
- Weight
- 624 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Ten patients with dysphagia due to metastatic carcinoma of the breast have been treated at Roswell Park Memorial Institute over the period from January 1960 through December 1968. This number represents less than 0.5:; of the total number of patients with metastatic breast disease seen during this period. All of these patients had disseminated metastases at the time dysphagia occurred. Because of this, systemic therapy is usually indicated. Six of seven patients who underwent adrenalectomy for dysphagia responded. In some instances chemotherapy has been efficacious.
π SIMILAR VOLUMES
Thomas J
## Background: Axillary lymph node metastases (alnm) are the most important predictor of survival in patients with t1 breast carcinoma. due to a relatively low incidence of axillary metastasis in tumors < or = 2 cm, the role of axillary lymph node dissection for these patients has been questioned.
## Background: Brain metastases are diagnosed in 15% of patients with metastatic breast carcinoma. most patients are treated with whole-brain radiotherapy (wbrt) and/or chemotherapy. the information on surgical results is sparse. ## Methods: Among 709 patients with tumors metastatic to the brain
## Abstract Esophageal cancer often leads to total or nearβtotal dysphagia, necessitating placement of nasogastric tubes for nutritional support. In patients with failed blind intubation or even failed fluoroscopicβguided tube placement, endoscopic guidance has a role to play. The catheterβoverβgui